← Back
Data updated: Mar 10, 2026
ROSEMONT PHARMS
Cardiovascular
ROSEMONT PHARMS is a pharmaceutical company focused on Cardiovascular. Key products include VOSTALLY.
2025
Since
2
Drugs
-
Trials
2
Approved (2yr)
Key Drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...